Nexera lite inert

Importance of the Topic

Protein and antibody drug analysis by HPLC is critical in biopharmaceutical quality control and research. High-salt mobile phases and protein adsorption to metal surfaces can cause corrosion, poor reproducibility, and compromised data quality. Reliable, metal-free chromatographic systems are essential to ensure accurate, stable, and long-term analysis of sensitive biomolecules.

Objectives and Study Overview

This whitepaper introduces the Nexera lite inert HPLC system, designed to overcome challenges in protein separation workflows. It reviews system performance in gel filtration, ion exchange chromatography, pH monitoring, and preparative fraction collection. The study aims to demonstrate improved data reliability, retention time stability, and flexible sample handling for both analytical and preparative applications.

Methodology and Instrumentation

The Nexera lite inert employs metal-free flow paths and high-precision pumps to prevent corrosion and adsorption. Key instruments include:

• Nexera lite inert HPLC system with SCL-40 controller
• TSKgel G3000SWXL size exclusion column and Shim-pack Bio Diol column
• RF-20A fluorescence detector and SPD-M40 UV detector
• pHM-40 inline pH monitor
• FRC-10A fraction collector
• TORAST-H Bio vials and Shim-pack bioseparation columns

Analyses were performed with phosphate buffers containing high concentrations of chloride salts and controlled flow rates (0.5 mL/min) at ambient or defined temperatures.

Key Results and Discussion

The system showed:

• Stable aggregate and monomer separation for monoclonal IgG, with no pump corrosion after exposure to 0.25 M KCl (gel filtration)
• Retention time repeatability of antibody aggregates with RSD of 0.08 % (n=5) under 0.2 M NaCl buffer
• Continuous mobile phase pH monitoring synchronized with chromatograms for traceability in ion exchange and size exclusion methods
• Detection of structural changes in GFP-tagged membrane proteins by fluorescence, resolving conformational shifts upon heat treatment
• Effective preparative recovery of labeled and unlabeled antibodies using FRC-10A with various tube formats

These results confirm the system’s robustness and precision in complex protein workflows.

Benefits and Practical Applications

The Nexera lite inert enables:

• Long-term, corrosion-free operation with high-salt mobile phases
• Reduced protein adsorption and improved sensitivity
• Precise solvent delivery for consistent retention times
• Integrated pH monitoring for quality assurance
• Flexible preparative separation and fraction collection for downstream processing

Future Trends and Potential Applications

Development areas include integration of advanced detectors for multi-modal analysis, enhanced automation for high-throughput bioseparation, and expanded inert materials for next-generation LC-MS compatibility. Real-time process analytical technology (PAT) and AI-driven chromatographic optimization will further improve biomanufacturing quality control.

Conclusion

The Nexera lite inert HPLC system addresses critical challenges in protein and antibody drug analysis by offering a fully inert flow path, precise solvent control, inline pH monitoring, and preparative fractionation options. Its deployment can enhance data reliability, workflow efficiency, and product quality in biopharmaceutical research and manufacturing.

References

Shimadzu Corporation. Nexera lite inert Application Note C190-E292B; 2022.
USP Monoclonal Antibody Reference Standard Data.
Shimadzu RF-20A and SPD-M40 Detector Specifications; 2022.
TORAST-H Bio Vial and Shim-pack Series Column Brochure; 2022.
pHM-40 pH Monitor Manual; 2022.